Metoprolol Surveillance Study Group. A long term surveillance study of metoprolol in hypertensive patients. Curr Ther Res1984; 35: 491–500.
2.
SchaeferEJ. HMG-CoA reductase inhibitors for hypercholesterolemia (letter). N Engl J Med1988; 319: 1222.
3.
NaranjoCABustoUSellersEMSandorPRuizIRobertsEA. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981; 30: 239–45.
4.
LyngstamORydenL. Metoprolol and atenolol administered once daily in primary hypertension. Acta Med Scand1981; 209: 261–6.
5.
EckernasSARoosBEKvidalPErikssonLOBlockGANeafusRP. The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: A comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hyper-cholesterolaemia. Br J Clin Pharmacol1993; 35: 284–9.
6.
EhrenbergBLLamon-FavaSCorbettKEMcNamaraJRDallalGESchaeferEJ. Comparison of the effects of pravastatin and lovastatin on sleep disturbances in hypercholesterolemic patients. Sleep1999; 22: 117–21.
